The most important thing:
- Benign prostatic hyperplasia and prostate cancer – similarities and differences
- Diagnostic pathway for men with prostate problems
- Maintaining a healthy prostate – habits and diet
Prostate health is critically important for every man over the age of 50. Statistics show that a large proportion of men of this age have prostate problems. The most common diagnoses are benign prostatic hyperplasia (BPH) and prostate cancer, which are often confused due to their similar initial symptoms.
However, the difference between them is fundamental – one is a benign enlargement that is not life-threatening, while the other is a potentially fatal disease. In this article, we will look at how to distinguish between the two conditions, what their specific characteristics are, and how to take care of the prostate, including with products such as Alphain.
What is benign prostatic hyperplasia (BPH)?
Benign prostatic hyperplasia is an enlargement of the prostate gland due to the proliferation of normal cells in its transitional zone around the urethra. This condition is a natural part of ageing and is due to hormonal changes with age.
The process begins in the transitional zone of the prostate – the area around the urinary tract. When the cells multiply, the gland presses on the urinary tract, making it more difficult to pass urine. The enlarged prostate thus hinders the normal emptying of the bladder.
The main symptoms of BPH include:
- Frequent urination during the day (every 1-2 hours)
- Getting up repeatedly during the night to urinate (nocturia)
- Weak urine stream – thin and interrupted
- Difficulty starting to urinate
- Feeling of incomplete bladder emptying
It is important to emphasise that BPH is not a precancerous condition. According to studies by the European Association of Urology, there is no causal relationship between benign hyperplasia and the development of carcinoma. (1) The two diseases can exist simultaneously, but they develop from different cells.
What is prostate cancer?
Prostate cancer is a malignant disease with uncontrolled cell growth. Unlike BPH, which originates in the transitional zone around the urethra, cancer starts in the peripheral zone—further away from the urethra—and therefore the early stages are often asymptomatic.
According to global data, prostate cancer is the second most commonly diagnosed cancer in men. (2) The disease often progresses slowly and, in many localised forms, may remain undetected for a decade, but in some patients the course is more aggressive—which is why monitoring is key.
In advanced stages, the following may occur:
- Blood in the urine or semen
- Pain during urination and ejaculation
- Constant pain in the back, pelvis or thighs
- Unexplained weight loss
- Bone pain in metastases
The diagnostic pathway for suspected prostate problems
When a man notices urinary symptoms or is of an age for a preventive examination, the diagnostic process goes through several consecutive steps.
The prostate-specific antigen (PSA) test is of utmost importance. Normal values depend on age, with the following serving as a guide: below 2.5 ng/ml for men under 50, below 3.5 for those between 50 and 60, and below 4.5 for those over 60.
It is important to know that elevated PSA does not necessarily mean cancer. It may be due to BPH, prostatitis, urinary tract infection, or even recent ejaculation or cycling. Therefore, it is recommended to avoid these activities 48 hours before the test.
A digital rectal examination is also of paramount importance for the diagnosis of prostate diseases. Although it sounds unpleasant, it is a quick and important examination that takes less than a minute. The urologist puts on a glove, applies lubricant and carefully palpates the prostate through the rectum. A normal prostate is walnut-sized, symmetrical and has an elastic consistency like the tip of the nose. In BPH, it is larger but retains its elasticity. In cancer, the urologist may feel hard lumps, irregularities or asymmetry – one side is harder or larger.
If the PSA or examination raises suspicion, magnetic resonance imaging is often performed. It “illuminates” suspicious areas and helps to avoid unnecessary biopsies; if a finding is made, it guides the doctor to take samples from exactly the right place.
If cancer is still suspected, a biopsy is performed. This is the only way to make a definitive diagnosis. Under ultrasound guidance, 12-14 small pieces of tissue are taken from different parts of the prostate with a thin needle. The procedure is performed under local anaesthesia and takes about 20 minutes. The samples are examined under a microscope for the presence of cancer cells. If any are found, the Gleason scale is used to assess the aggressiveness of the tumour on a scale from 6 (least aggressive) to 10 (highly aggressive).
Key differences between BPH and prostate cancer
Distinguishing between the two conditions is extremely important for proper treatment. BPH is a benign process, while cancer is malignant. In benign hyperplasia, urinary symptoms appear from the outset, as the enlargement affects the central part of the prostate around the urethra. In cancer, symptoms are often absent in the early stages because the tumour grows in the peripheral zone.
Localisation is another key difference. BPH mainly originates in the transitional zone around the urethra, while around 70–75% of malignant tumours occur in the peripheral zone.
The rate of development also varies significantly. Benign hyperplasia progresses slowly over the years. Cancer can range from very slow-growing forms to aggressive tumours that metastasise rapidly.
When examining PSA levels, characteristic differences are observed. In BPH, the values are slightly elevated and increase slowly. In cancer, the levels are significantly elevated and rise more rapidly.
Digital rectal examination (rectal touch) also yields different findings. In BPH, the prostate is symmetrically enlarged, with an elastic consistency. In cancer, hard nodules, asymmetry or irregularities on the surface of the gland can be felt.
The prognosis is perhaps the most important difference. BPH, although unpleasant, is not life-threatening and is well controlled with medication. Prostate cancer is potentially fatal, especially if detected at an advanced stage.
It is important to know that both conditions can exist simultaneously. Therefore, regular check-ups are mandatory even with a confirmed benign diagnosis.
How to maintain a healthy prostate
It is possible to slow down changes in the prostate with age and reduce the chances of malignant tumours. Maintaining a healthy prostate requires a comprehensive approach. Lifestyle recommendations are fundamental to the prevention of prostate diseases:
- Maintain a healthy weight – Being overweight and having a sedentary lifestyle are associated with worse urinary symptoms and a higher risk of recurrence; weight reduction and more exercise really help.
- Be physically active – Aim for at least 150 minutes of moderate aerobic activity (brisk walking, cycling, swimming) per week. More active men and those who sit less are less likely to develop new symptoms.
- Avoid prolonged sitting – Prolonged sitting is associated with more urinary complaints; get up and stretch every 45–60 minutes.
- Limit alcohol and caffeine – These can irritate the bladder and increase frequent night-time urination; reduce your fluid intake in the evening.
Proper nutrition plays a key role. Dietary patterns, rather than “miracle” foods, have been most extensively studied. The Mediterranean diet—rich in vegetables, fruits, whole grains, legumes, olive oil, and fish—has a positive effect on prostate health:
Proper nutrition plays a key role. Dietary patterns, rather than “miracle” foods, have been best studied. The Mediterranean diet—rich in vegetables, fruits, whole grains, legumes, olive oil, and fish—has a positive effect on prostate health:
- Tomatoes and lycopene. Higher intake and higher blood levels are associated with a lower risk of cancer, including prostate cancer.
- Oily fish. Omega-3 fatty acids have anti-inflammatory properties; eating fish 1–2 times a week provides the body with the necessary amount.
- Nuts. Brazil nuts are a rich source of selenium (a powerful antioxidant) — 1–2 nuts are enough.
- Green leafy vegetables. They provide folate, vitamin K and other phytonutrients.
The male body can be further supported by Alphain — a scientifically developed formula for maintaining prostate health. The product contributes to normal sperm production and optimal testosterone levels in the body, which affects changes in the prostate with age. Alphain also aids urinary function in benign prostatic hyperplasia.
Final words
Distinguishing between benign hyperplasia and prostate cancer is critical for the correct therapeutic approach. The two conditions have different natures, development and health consequences.
Timely testing is key – every man over 50 should have his PSA tested and undergo a urological examination. If urinary symptoms occur, consultation with a specialist should not be delayed. Maintaining a healthy prostate through a healthy lifestyle and products such as Alphain creates conditions for preserving the function of the gland and preventing complications.
FAQ:
- Does BPH surgery affect sexual function and what are the chances of recovery?BPH surgery (transurethral resection) often leads to retrograde ejaculation – the semen goes into the bladder instead of out, which does not affect orgasm but makes natural conception difficult/impossible. Erectile function is usually preserved in most men and even improves in some, especially with modern sparing techniques. With radical prostatectomy for prostate cancer, the risk of erectile dysfunction is higher, but modern approaches and rehabilitation help with recovery within 12–24 months.
- If my father or brother has prostate cancer, how much higher is my risk and when should I start screening? If a first-degree relative (father, brother) has prostate cancer, your risk is about 2–3 times higher than average. If two or more relatives are affected, the risk increases several times and is higher if they were diagnosed before the age of 60. In such cases, start discussing PSA screening at the age of 40–45 (or earlier, depending on individual risk).
Sources:
- EAU (European Association of Urology)
- EAU Guidelines on Prostate Cancer
- EAU Guidelines Urinary Tract Symptoms
- AUA (American Urological Association)
- AUA Guidelines
- National Cancer Institute (NCI)
- IARC / WHO (Globocan)
- Prostate Cancer UK
- NHS (UK)
- NCBI Bookshelf
- European Urology
